Skip to main content
Log in

Therapeutic Potential of the Proteasome Inhibitor Bortezomib on Titanium Particle-Induced Inflammation in a Murine Model

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Wear particle-induced aseptic loosening has been recognized as a harmful inflammatory process that jeopardizes the longevity of total joint replacement. The proteasome controls the activation of NF-κB and subsequent inflammatory mediators, such as TNF-α and IL-1β; thus, we investigated whether proteasome inhibition can ameliorate wear particle-induced inflammation in a murine model. A total of 48 BALB/C mice were divided into four groups. Titanium (Ti) particles were injected into the established air pouches of all mice (except negative controls) to provoke inflammation, and then 0.1 or 0.5 mg/kg of Bortezomib (Bzb, a proteasome inhibitor) was administered to ameliorate the inflammation response, while air pouches without Bzb administration were used as loading controls. The air pouches were harvested 2 or 7 days after Bzb injection for molecular and histological analyses. Inflammation responses in the air pouch tissues of Bzb treatment groups are lower than those in the Ti-stimulated group, and this occurs in a dose-dependent manner. Bzb can significantly attenuate the severity of Ti-induced inflammation in air pouches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Daniel, J., P. Pynsent, and D. McMinn. 2004. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. Journal of Bone and Joint Surgery. British Volume 86(2): 177–184.

    Article  CAS  Google Scholar 

  2. Sundfeldt, M., L.V. Carlsson, C.B. Johansson, P. Thomsen, and C. Gretzer. 2006. Aseptic loosening, not only a question of wear: A review of different theories. Acta Orthopaedica 77(2): 177–197.

    Article  PubMed  Google Scholar 

  3. Mabilleau, G., Y.M. Kwon, H. Pandit, D.W. Murray, and A. Sabokbar. 2008. Metal-on-metal hip resurfacing arthroplasty: A review of periprosthetic biological reactions. Acta Orthopaedica 79(6): 734–747.

    Article  PubMed  Google Scholar 

  4. Purdue, P.E., P. Koulouvaris, B.J. Nestor, and T.P. Sculco. 2006. The central role of wear debris in periprosthetic osteolysis. HSS Journal 2(2): 102–113.

    Article  PubMed  Google Scholar 

  5. Ingham, E., and J. Fisher. 2005. The role of macrophages in osteolysis of total joint replacement. Biomaterials 26(11): 1271–1286.

    Article  PubMed  CAS  Google Scholar 

  6. Ren, W., X.H. Li, B.D. Chen, and P.H. Wooley. 2004. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-κB activity. Journal of Orthopaedic Research 22(1): 21–29.

    Article  PubMed  CAS  Google Scholar 

  7. Goodman, S.B., M. Trindade, T. Ma, M. Genovese, and R.L. Smith. 2005. Pharmacologic modulation of periprosthetic osteolysis. Clinical Orthopaedics and Related Research 430: 39–45.

    Article  PubMed  Google Scholar 

  8. Paramore, A., and S. Frantz. 2003. Bortezomib. Nature Reviews. Drug Discovery 2(8): 611–612.

    Article  PubMed  CAS  Google Scholar 

  9. Diptendu, S., L. Khanh, K. Tapas, J. Bryan, P. Thomas, B. Lionel, and P. Edward. 2006. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-γ mechanistic insights and implications for periprosthetic osteolysis. Journal of Bone and Joint Surgery. American Volume 88(4): 788–799.

    Article  Google Scholar 

  10. Wooley, P.H., R. Morren, J. Andary, S. Sud, S.Y. Yang, L. Mayton, D. Markel, A. Sieving, and S. Nasser. 2002. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23(2): 517–526.

    Article  PubMed  CAS  Google Scholar 

  11. Ren, W., D. Markel, R. Schwendener, Y. Ding, B. Wu, and P. Wooley. 2008. Macrophage depletion diminishes implant-wear-induced inflammatory osteolysis in a mouse model. Journal of Biomedical Materials Research. Part A 85(4): 1043–1051.

    Article  PubMed  Google Scholar 

  12. Edwards, J., A. Sedgwick, and D. Willoughby. 1981. The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system. The Journal of Pathology 134(2): 147–156.

    Article  PubMed  CAS  Google Scholar 

  13. Ciechanover, A. 1994. The ubiquitin–proteasome proteolytic pathway. Cell 79(1): 13–21.

    Article  PubMed  CAS  Google Scholar 

  14. Goldberg, A.L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426(6968): 895–899.

    Article  PubMed  CAS  Google Scholar 

  15. Richardson, P.G., B. Barlogie, J. Berenson, S. Singhal, S. Jagannath, D. Irwin, S.V. Rajkumar, G. Srkalovic, M. Alsina, and R. Alexanian. 2003. A phase 2 study of bortezomib in relapsed, refractory myeloma. The New England Journal of Medicine 348(26): 2609–2617.

    Article  PubMed  CAS  Google Scholar 

  16. Lee, S.W., J.H. Kim, Y.B. Park, and S.K. Lee. 2009. Bortezomib attenuates murine collagen-induced arthritis. Annals of the Rheumatic Diseases 68(11): 1761–1767.

    Article  PubMed  CAS  Google Scholar 

  17. Yannaki, E., A. Papadopoulou, E. Athanasiou, P. Kaloyannidis, A. Paraskeva, D. Bougiouklis, P. Palladas, M. Yiangou, and A. Anagnostopoulos. 2010. The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats. Arthritis and Rheumatism 62(11): 3277–3288.

    Article  PubMed  CAS  Google Scholar 

  18. Lawrence, T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology 1(6): a001651.

    Article  PubMed  Google Scholar 

  19. Mankan, A.K., M.W. Lawless, S.G. Gray, D. Kelleher, and R. McManus. 2009. NF-κB regulation: The nuclear response. Journal of Cellular and Molecular Medicine 13(4): 631–643.

    Article  PubMed  CAS  Google Scholar 

  20. Karin, M., Y. Yamamoto, and Q.M. Wang. 2004. The IKK NF-κB system: A treasure trove for drug development. Nature Reviews. Drug Discovery 3(1): 17–26.

    Article  PubMed  CAS  Google Scholar 

  21. Jimi, E., K. Aoki, H. Saito, F. D’Acquisto, M.J. May, I. Nakamura, T. Sudo, T. Kojima, F. Okamoto, and H. Fukushima. 2004. Selective inhibition of NF-kappaB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nature Medicine 10(6): 617–624.

    Article  PubMed  CAS  Google Scholar 

  22. Xu, J., H.F. Wu, E.S.M. Ang, K. Yip, M. Woloszyn, M.H. Zheng, and R.X. Tan. 2009. NF-κB modulators in osteolytic bone diseases. Cytokine & Growth Factor Reviews 20(1): 7–17.

    Article  CAS  Google Scholar 

  23. Jones, L.C., C. Frondoza, and D.S. Hungerford. 1999. Immunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular components. Journal of Biomedical Materials Research 48(6): 889–898.

    Article  PubMed  CAS  Google Scholar 

  24. Stea, S., M. Visentin, D. Granchi, G. Ciapetti, M. Donati, A. Sudanese, C. Zanotti, and A. Toni. 2000. Cytokines and osteolysis around total hip prostheses. Cytokine 12(10): 1575–1579.

    Article  PubMed  CAS  Google Scholar 

  25. Epstein, F.H., P.J. Barnes, and M. Karin. 1997. Nuclear factor-кB-a pivotal transcription factor in chronic inflammatory disease. The New England Journal of Medicine 336(15): 1066–1071.

    Article  Google Scholar 

  26. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunology Today 15(2): 74–80.

    Article  PubMed  CAS  Google Scholar 

  27. Lin, E., S.E. Calvano, and S.F. Lowry. 2000. Inflammatory cytokines and cell response in surgery. Surgery 127(2): 117–126.

    Article  PubMed  CAS  Google Scholar 

  28. Cheng, T., G.Y. Zhang, C.J. Guo, and X. Zhang. 2010. Effects of NF-κB inhibitor on titanium particulate-induced inflammation in a murine model. Journal of Surgical Research 162(2): 225–230.

    Article  PubMed  CAS  Google Scholar 

  29. Zhou, F., X. Zhu, H. Mao, H. Yang, D. Geng, and Y. Xu. 2010. Effects of a cannabinoid receptor 2 selective antagonist on the inflammatory reaction to titanium particles in vivo and in vitro. The Journal of International Medical Research 38(6): 2023–2032.

    PubMed  CAS  Google Scholar 

  30. Hofbauer, L., D. Lacey, C. Dunstan, T. Spelsberg, B. Riggs, and S. Khosla. 1999. Interleukin-1 [beta] and tumor necrosis factor-[alpha], but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25(3): 255–259.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Integration of Medicine and Engineering Foundation of Shanghai Jiaotong University (YG2010MS33).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xianlong Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mao, X., Pan, X., Cheng, T. et al. Therapeutic Potential of the Proteasome Inhibitor Bortezomib on Titanium Particle-Induced Inflammation in a Murine Model. Inflammation 35, 905–912 (2012). https://doi.org/10.1007/s10753-011-9392-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-011-9392-7

KEY WORDS

Navigation